Hap Trading, LLC Athersys, Inc Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.18 - $0.86 $1,980 - $9,460	-11,000 Reduced 21.07%	41,200 $0
Q1 2022 May 12, 2022	BUY	$0.6 - $1.06 $15,060 - $26,606	25,100 Added 92.62%	52,200 $4,000
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.4 $10,625 - $17,500	-12,500 Reduced 31.57%	27,100 $4,000
Q1 2021 May 14, 2021	BUY	$1.61 - $2.77 $8,855 - $15,235	5,500 Added 16.13%	39,600 $3,000
Q4 2020 Feb 16, 2021	SELL	$1.55 - $2.24 $12,400 - $17,920	-8,000 Reduced 19.0%	34,100 $4,000
Q3 2020 Nov 13, 2020	SELL	$1.91 - $3.08 $110,398 - $178,024	-57,800 Reduced 57.86%	42,100 $4,000
Q2 2020 Aug 10, 2020	BUY	$1.97 - $3.98 $129,626 - $261,884	65,800 Added 192.96%	99,900 $37,000
Q1 2020 May 08, 2020	BUY	$1.17 - $3.0 $39,897 - $102,300	34,100 New	34,100 $26,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.